Table 2 Comparison of demographic, clinical and laboratory parameters of the patients treated with or without UTI
From: Association of SGLT-2 inhibitors with bacterial urinary tract infection in type 2 diabetes
UTI | p | ||
|---|---|---|---|
No (n = 41) | Yes (n = 60) | ||
n (%) or median (min-max) | n (%) or median (min-max) | ||
Sex (female) | 23 (56.1) | 34 (56.7) | 0.558 c |
Age (year) | 57 (45–67) | 55.5 (45–67) | 0.469 u |
BMI (kg/m2) | 28 (24–34) | 32 (25–41) | < 0.001u |
HbA1c (%) | 5.8 (5.6–7.8) | 7.7 (5.6–11) | < 0.001u |
FBG (mg/dL) | 156 (112–234) | 156 (112–234) | 0.764 u |
Glucosuria (present) | 11 (26.8) | 51 (85.0) | < 0.001c |
SGLT-2i (+) | 0 (0.0) | 51 (85.0) | < 0.001c |